Indications for BETOPTIC S:
Open-angle glaucoma. Ocular hypertension.
Remove contact lenses before use; may reinsert 15mins after instillation. 1–2 drops twice daily.
Sinus bradycardia. Greater than 1st-degree AV block. Cardiogenic shock. Overt cardiac failure.
History of cardiac failure or heart block. Discontinue at 1st sign of cardiac failure. COPD. Asthma. Pulmonary impairment. Measure intraocular pressure during 1st month of treatment. Diabetes (esp. labile). Vascular insufficiency; consider alternative therapy if reduced cerebral blood flow or Raynaud's phenomenon develop. History of atopy or anaphylaxis. May mask hypoglycemia and hyperthyroidism. Discontinue before general anesthesia. Avoid abrupt cessation. Pregnancy (Cat.C). Nursing mothers.
May potentiate or be potentiated by systemic β-blockers. May potentiate reserpine, hypoglycemics. May antagonize adrenergic psychotropics. Additive hypotension and/or marked bradycardia with concomitant calcium antagonists, antiarrhythmics, digitalis.
Transient discomfort, tearing. Rarely: decreased corneal sensitivity, erythema, itch, corneal punctate staining, keratitis, anisocoria, photophobia, depression, headache, bradycardia, dyspnea, hives.
Susp—2.5mL, 5mL, 10mL, 15mL